- Home
- BCAL vs CGEM Comparison
BCAL vs CGEM Comparison
Compare BCAL & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAL
- CGEM
- Stock Information
- Founded
- BCAL 2001
- CGEM 2016
- Country
- BCAL United States
- CGEM United States
- Employees
- BCAL 204
- CGEM N/A
- Industry
- BCAL Major Banks
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- BCAL Finance
- CGEM Health Care
- Exchange
- BCAL Nasdaq
- CGEM Nasdaq
- Market Cap
- BCAL 464.0M
- CGEM 506.1M
- IPO Year
- BCAL N/A
- CGEM 2021
- Fundamental
- Price
- BCAL $14.38
- CGEM $8.02
- Analyst Decision
- BCAL Strong Buy
- CGEM Strong Buy
- Analyst Count
- BCAL 1
- CGEM 8
- Target Price
- BCAL $20.00
- CGEM $32.86
- AVG Volume (30 Days)
- BCAL 120.2K
- CGEM 411.9K
- Earning Date
- BCAL 05-07-2025
- CGEM 05-14-2025
- Dividend Yield
- BCAL N/A
- CGEM N/A
- EPS Growth
- BCAL N/A
- CGEM N/A
- EPS
- BCAL 0.22
- CGEM N/A
- Revenue
- BCAL $106,054,000.00
- CGEM N/A
- Revenue This Year
- BCAL $77.98
- CGEM N/A
- Revenue Next Year
- BCAL $5.12
- CGEM $278.37
- P/E Ratio
- BCAL $67.09
- CGEM N/A
- Revenue Growth
- BCAL 9.78
- CGEM N/A
- 52 Week Low
- BCAL $12.30
- CGEM $7.90
- 52 Week High
- BCAL $18.49
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- BCAL 28.55
- CGEM 36.91
- Support Level
- BCAL $14.70
- CGEM $8.01
- Resistance Level
- BCAL $16.24
- CGEM $9.16
- Average True Range (ATR)
- BCAL 0.69
- CGEM 0.48
- MACD
- BCAL -0.03
- CGEM -0.00
- Stochastic Oscillator
- BCAL 1.94
- CGEM 4.90
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through strong partnerships with its clients.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.